Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.

Literature DB >> 33868664

Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.

Claudia Phen¹, Charina M Ramirez¹.

Abstract

Entities: Disease

Year: 2021 PMID： 33868664 PMCID： PMC8043692 DOI： 10.1002/cld.1008

Source DB: PubMed Journal: Clin Liver Dis (Hoboken) ISSN： 2046-2484

Keyword Cloud
References

× No keyword cloud information.

19 in total

1. Liver transplantation for nonalcoholic steatohepatitis in young patients.

Authors: Naim Alkhouri; Ibrahim A Hanouneh; Nizar N Zein; Rocio Lopez; Dympna Kelly; Bijan Eghtesad; John J Fung
Journal: Transpl Int Date: 2016-04 Impact factor: 3.782

2. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors: Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal: J Pediatr Gastroenterol Nutr Date: 2017-02 Impact factor: 2.839

3. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.

Authors: Panu K Luukkonen; You Zhou; Tuulia Hyötyläinen; Marja Leivonen; Johanna Arola; Marju Orho-Melander; Matej Orešič; Hannele Yki-Järvinen
Journal: J Hepatol Date: 2016-08-09 Impact factor: 25.083

Review 4. Genetics and epigenetics of NAFLD and NASH: Clinical impact.

Authors: Mohammed Eslam; Luca Valenti; Stefano Romeo
Journal: J Hepatol Date: 2017-11-06 Impact factor: 25.083

5. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.

Authors: Noura S Abul-Husn; Xiping Cheng; Alexander H Li; Yurong Xin; Claudia Schurmann; Panayiotis Stevis; Yashu Liu; Julia Kozlitina; Stefan Stender; G Craig Wood; Ann N Stepanchick; Matthew D Still; Shane McCarthy; Colm O'Dushlaine; Jonathan S Packer; Suganthi Balasubramanian; Nehal Gosalia; David Esopi; Sun Y Kim; Semanti Mukherjee; Alexander E Lopez; Erin D Fuller; John Penn; Xin Chu; Jonathan Z Luo; Uyenlinh L Mirshahi; David J Carey; Christopher D Still; Michael D Feldman; Aeron Small; Scott M Damrauer; Daniel J Rader; Brian Zambrowicz; William Olson; Andrew J Murphy; Ingrid B Borecki; Alan R Shuldiner; Jeffrey G Reid; John D Overton; George D Yancopoulos; Helen H Hobbs; Jonathan C Cohen; Omri Gottesman; Tanya M Teslovich; Aris Baras; Tooraj Mirshahi; Jesper Gromada; Frederick E Dewey
Journal: N Engl J Med Date: 2018-03-22 Impact factor: 91.245

Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.

1. Liver transplantation for nonalcoholic steatohepatitis in young patients.

2. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

3. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.

Review 4. Genetics and epigenetics of NAFLD and NASH: Clinical impact.

5. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.

Review 6. Liver fibrosis and repair: immune regulation of wound healing in a solid organ.

Review 7. Molecular mediators of hepatic steatosis and liver injury.

Review 8. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.

Review 9. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Review 10. NAFLD in children: new genes, new diagnostic modalities and new drugs.